Search results
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 4 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...
Tempus AI shares jump 8% in strong Nasdaq debut as US IPO market thaws
Reuters via Yahoo Finance· 8 hours agoThe stock opened at $40 apiece, compared with the initial public offering (IPO) price of $37. The...
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 2 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks· 19 hours agoAn FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 2 days agoAbrahams rates Regeneron stock an outperform and raised his price target to 1,229 from 1,200. Rivals...
European Midday Briefing: Stocks, Euro Hit by European Political Upheaval
Morningstar· 5 days agoEuropean stocks fell on Monday after European elections resulted in strong gains for right-wing Euroskeptic parties, prompting Emmanuel Macron to call a snap election in France. The main takeaways ...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 4 days agoModerna is also evaluating mRNA-1345 in early-stage studies for high-risk adults, as well as...
Most CEOs are defeating attempts to vote down their pay. Can Tesla's Elon Musk do the same?
Yahoo Finance· 5 days agoMost bosses are defeating shareholder attempts so far this year to tamp down their pay. The question...
This startup helps Americans get Ozempic and Adderall by using overseas freelancers
Quartz· 3 days agoA startup is working to help Americans navigate ongoing shortages of highly-coveted drugs like...
Why Regeneron Stock Finally Joined The 1,000-Club
Investor's Business Daily· 2 days agoEnthusiasm is growing for a looming approval in COPD treatment.